Research / POLA / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-22-032038 General Corporate
Capex intensity 33th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.59% · OPTIONAL · VALID
Operating cash generation 6th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-130.11% · OPTIONAL · VALID
Revenue growth 29th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
-58.73% · CORE · VALID
Inventory pressure 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
915.35% · OPTIONAL · VALID
Gross margin 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
-14.47% · CORE · VALID
Operating margin 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
-139.19% · CORE · VALID
R&D intensity 83th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18.69% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
30.17% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 6/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 6/6 normalized Level 3 Jun 30, 2023 6/6 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.16%
Current 0.59%
Delta 0.42% Cash Generation Decreased
Previous -34.25%
Current -130.11%
Delta -95.86% Growth Decreased
Previous -11.82%
Current -58.73%
Delta -46.91% Inventory Pressure Increased
Previous 280.42%
Current 915.35%
Delta 634.93% Margin Decreased
Previous 24.82%
Current -14.47%
Delta -39.29% Profitability Decreased
Previous -16.96%
Current -139.19%
Delta -122.23% R And D Intensity Increased
Previous 8.19%
Current 18.69%
Delta 10.50% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.